Literature DB >> 11171987

Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1.

Y Shen1, G Devgan, J E Darnell, J F Bromberg.   

Abstract

Stats1 and 3 (signal transducers and activators of transcription) can be activated simultaneously, although not necessarily to the same degree or duration, by the interaction of cells with the same polypeptide ligand (EGF, PDGF, or high concentrations of IL-6, for example). However, these two Stat proteins can mediate opposing effects on cell growth and survival. Stat1 activation slows growth and promotes apoptosis. In contrast, activated Stat3 can protect cells from apoptosis. Furthermore, a constitutively active form of Stat3, Stat3-C (bridged by S-S linkages between cysteines instead of phosphotyrosines) can induce cellular transformation of fibroblasts. We have determined that fibroblasts transformed by Stat3-C are more resistant to proapoptotic stimuli than nontransformed cells. Also, to examine the potential opposing roles in apoptosis of Stat1 and Stat3, we studied the cervical carcinoma-derived cell line, Me180, which undergoes Stat1-dependent, IFN gamma-induced apoptosis. Me180 cells that express Stat3-C are protected against IFN gamma-mediated apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171987      PMCID: PMC29293          DOI: 10.1073/pnas.98.4.1543

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli.

Authors:  J K Taylor; Q Q Zhang; B P Monia; E G Marcusson; N M Dean
Journal:  Oncogene       Date:  1999-08-05       Impact factor: 9.867

2.  c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release.

Authors:  P Juin; A O Hueber; T Littlewood; G Evan
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

3.  Stat3 as an oncogene.

Authors:  J F Bromberg; M H Wrzeszczynska; G Devgan; Y Zhao; R G Pestell; C Albanese; J E Darnell
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

4.  Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas.

Authors:  J Peli; M Schröter; C Rudaz; M Hahne; C Meyer; E Reichmann; J Tschopp
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

5.  Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.

Authors:  G Niu; R Heller; R Catlett-Falcone; D Coppola; M Jaroszeski; W Dalton; R Jove; H Yu
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

6.  Creation of human tumour cells with defined genetic elements.

Authors:  W C Hahn; C M Counter; A S Lundberg; R L Beijersbergen; M W Brooks; R A Weinberg
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

7.  Loss of STAT1 expression confers resistance to IFN-gamma-induced apoptosis in ME180 cells.

Authors:  K Y Lee; E Anderson; K Madani; G D Rosen
Journal:  FEBS Lett       Date:  1999-10-15       Impact factor: 4.124

8.  Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells.

Authors:  M Nielsen; C G Kaestel; K W Eriksen; A Woetmann; T Stokkedal; K Kaltoft; C Geisler; C Röpke; N Odum
Journal:  Leukemia       Date:  1999-05       Impact factor: 11.528

9.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.

Authors:  R Catlett-Falcone; T H Landowski; M M Oshiro; J Turkson; A Levitzki; R Savino; G Ciliberto; L Moscinski; J L Fernández-Luna; G Nuñez; W S Dalton; R Jove
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

Review 10.  Survivin apoptosis: an interloper between cell death and cell proliferation in cancer.

Authors:  D C Altieri; P C Marchisio; C Marchisio
Journal:  Lab Invest       Date:  1999-11       Impact factor: 5.662

View more
  72 in total

1.  γ-Tocotrienol but not γ-tocopherol blocks STAT3 cell signaling pathway through induction of protein-tyrosine phosphatase SHP-1 and sensitizes tumor cells to chemotherapeutic agents.

Authors:  Ramaswamy Kannappan; Vivek R Yadav; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

Review 2.  Roles of apoptosis in airway epithelia.

Authors:  Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-26       Impact factor: 6.914

3.  Phaeosphaeride A, an inhibitor of STAT3-dependent signaling isolated from an endophytic fungus.

Authors:  Katherine N Maloney; Wenshan Hao; Jun Xu; Jay Gibbons; John Hucul; Deborah Roll; Sean F Brady; Frank C Schroeder; Jon Clardy
Journal:  Org Lett       Date:  2006-08-31       Impact factor: 6.005

4.  A quantitative high-throughput screen for modulators of IL-6 signaling: a model for interrogating biological networks using chemical libraries.

Authors:  Ronald L Johnson; Ruili Huang; Ajit Jadhav; Noel Southall; Jennifer Wichterman; Ryan MacArthur; Menghang Xia; Kun Bi; John Printen; Christopher P Austin; James Inglese
Journal:  Mol Biosyst       Date:  2009-06-19

5.  Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth.

Authors:  Paul L Leong; Genevieve A Andrews; Daniel E Johnson; Kevin F Dyer; Sichuan Xi; Jeffrey C Mai; Paul D Robbins; Seshu Gadiparthi; Nancy A Burke; Simon F Watkins; Jennifer Rubin Grandis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-14       Impact factor: 11.205

6.  Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells.

Authors:  Simi T Ahmed; James E Darnell
Journal:  Biochem Biophys Res Commun       Date:  2008-12-12       Impact factor: 3.575

7.  Cryptotanshinone, a Stat3 inhibitor, suppresses colorectal cancer proliferation and growth in vitro.

Authors:  Weidong Li; Shakir M Saud; Matthew R Young; Nancy H Colburn; Baojin Hua
Journal:  Mol Cell Biochem       Date:  2015-04-26       Impact factor: 3.396

Review 8.  The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors.

Authors:  Martin G Belinsky; Lori Rink; Kathy Q Cai; Michael F Ochs; Burton Eisenberg; Min Huang; Margaret von Mehren; Andrew K Godwin
Journal:  Cell Cycle       Date:  2008-10-07       Impact factor: 4.534

9.  Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes.

Authors:  Chi Tarn; Lin Zou; Ronald L Hullinger; Ourania M Andrisani
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 10.  AIP1 in graft arteriosclerosis.

Authors:  Wang Min; Jordan S Pober
Journal:  Trends Cardiovasc Med       Date:  2011-11       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.